Site Search
Search Results
ACS CAN Issues New Recommendations to Increase Access to Cancer Biomarker Testing
Washington, D.C.– The American Cancer Society Cancer Action Network (ACS CAN) released new policy recommendations today to increase uptake of biomarker testing and advance the use of precision medicine in cancer care. The recommendations follow the release of new data that shows access is not keeping up with innovation when it comes to biomarker testing. Progress in improving cancer outcomes increasingly involves the use of precision medicine, which uses information about a ...
State Senate Committee Votes to Increase Access to Innovative Testing and Lifesaving Treatments
... here . Sacramento, Calif. – The California Senate Health Committee voted Wednesday evening to advance a bill that would increase access to biomarker testing, a critical step in accessing precision medicine treatments that can lead to fewer side effects, improved survival, better quality of life and potentially lower costs for cancer patients. Senate Bill 912 would ensure comprehensive biomarker testing is covered by more insurance plans, including Medi-Cal, when supported by medical and scientific evidence. The bill moves on to ...
Governor Ducey Signs Legislation to Increase Access to Innovative Testing that Can Match Patients with Most Effective Treatments
Phoenix, Ariz. – Today, Governor Doug Ducey signed legislation that will ensure biomarker testing is covered by more insurance plans, including Medicaid, when patients need it. The new law will enable more Arizonans to benefit from biomarker testing, a critical step in accessing precision medicine treatments that can lead to fewer side effects, improved survival, better ...
FL Legislative Briefing: The Promise of Precision Medicine in Cancer Care: Improving Patient Access to Targeted Cancer Therapies - A Virtual Event
... an overview of the rapidly advancing world of precision medicine in cancer care, as well as the importance of increasing patient access to biomarker testing and targeted cancer therapies. A panel of experts will discuss exciting recent developments in precision medicine, the current landscape in terms of patient access to appropriate biomarker testing, and strategies to reduce barriers to testing. PANELISTS: Moderator: Michael Diaz, MD, Assistant Managing Physician & ...
New Paper Finds Barriers to Equitable Discovery and Implementation of Pharmacogenomic Testing in Cancer Care Despite its Power to Improve Patient Outcomes
... February 22, 2024 – A new paper released today in the Journal of Clinical Oncology finds that while incorporating pharmacogenomic (PGx) testing into cancer care can help improve patient outcomes, barriers to PGx testing, discovery, and implementation are impacting its adoption and ... from them.” ACS CAN is working to improve access to PGx testing through its state advocacy work to expand insurance coverage of comprehensive biomarker testing, which includes PGx testing. Biomarker testing is a critical step toward accessing precision medicine, including targeted therapies; however, not all patients who could benefit ...
Virtual Policy Forum to Highlight the Role of Research in Equitable Access to High-Quality Cancer Care in California
... all levels of government that reduce disparities in cancer care. Among these are Senate Bill 912, a legislation that would ensure comprehensive biomarker testing is covered by more insurance plans – including Medi-Cal; and the California Cancer Care Equity Act (SB 987), which would ensure ...